News

$60,000 of AVADEL PHARMACEUTICALS PLC lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act."

You can find more data on corporate lobbying on Quiver Quantitative.

AVDL Insider Trading Activity

AVDL insiders have traded $AVDL stock on the open market 7 times in the past 6 months. Of those trades, 7 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $AVDL stock by insiders over the last 6 months:

• THOMAS S MCHUGH (Chief Financial Officer) has traded it 2 times. They made 2 purchases, buying 7,300 shares and 0 sales.
• GEOFFREY MICHAEL GLASS has traded it 2 times. They made 2 purchases, buying 20,279 shares and 0 sales.
• GREGORY J DIVIS (Chief Executive Officer) has traded it 2 times. They made 2 purchases, buying 10,000 shares and 0 sales.
• LINDA PALCZUK purchased 3,000 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

AVDL Hedge Fund Activity

We have seen 101 institutional investors add shares of AVDL stock to their portfolio, and 63 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• VIVO CAPITAL, LLC added 2,684,109 shares (+inf%) to their portfolio in Q3 2024
• GOLDMAN SACHS GROUP INC added 1,859,968 shares (+inf%) to their portfolio in Q3 2024
• POLAR CAPITAL HOLDINGS PLC removed 1,726,387 shares (-26.3%) from their portfolio in Q3 2024
• TRI LOCUM PARTNERS LP added 1,660,955 shares (+inf%) to their portfolio in Q3 2024
• ADAGE CAPITAL PARTNERS GP, L.L.C. removed 994,738 shares (-100.0%) from their portfolio in Q3 2024
• MILLENNIUM MANAGEMENT LLC added 964,257 shares (+7007.2%) to their portfolio in Q3 2024
• PENN CAPITAL MANAGEMENT COMPANY, LLC added 608,399 shares (+inf%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

This article was originally published on Quiver News, read the full story.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.